These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20044651)

  • 1. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K; Völlm B; Rücker G; Timmer A; Stoffers JM
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    CNS Drugs; 2008; 22(8):671-92. PubMed ID: 18601305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.
    Bellino S; Rinaldi C; Bozzatello P; Bogetto F
    Curr Med Chem; 2011; 18(22):3322-9. PubMed ID: 21728970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology of borderline personality disorder.
    Raj YP
    Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for people with borderline personality disorder.
    Binks CA; Fenton M; McCarthy L; Lee T; Adams CE; Duggan C
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005653. PubMed ID: 16437535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications in the treatment of borderline personality disorder 2006.
    Mercer D
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics, antidepressants, anticonvulsants, and placebo on the symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials.
    Vita A; De Peri L; Sacchetti E
    J Clin Psychopharmacol; 2011 Oct; 31(5):613-24. PubMed ID: 21869691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine for people with borderline personality disorder: a RCT.
    Crawford MJ; Sanatinia R; Barrett B; Cunningham G; Dale O; Ganguli P; Lawrence-Smith G; Leeson VC; Lemonsky F; Lykomitrou-Matthews G; Montgomery A; Morriss R; Munjiza J; Paton C; Skorodzien I; Singh V; Tan W; Tyrer P; Reilly JG
    Health Technol Assess; 2018 Apr; 22(17):1-68. PubMed ID: 29651981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
    Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
    CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L; Silk KR
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial.
    Chanen AM; Betts J; Jackson H; McGorry P; Nelson B; Cotton SM; Bartholomeusz C; Jovev M; Ratheesh A; Davey C; Pantelis C; McCutcheon L; Francey S; Bhaduri A; Lowe D; Rayner V; Thompson K
    Early Interv Psychiatry; 2019 Dec; 13(6):1373-1381. PubMed ID: 30689305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.